About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
CDK9
MCL1
CDK4/6
SMARCA2
Discovery Engine
Publications
Clinical Trials
Overview
PRT2527 Trials
PRT1419 Trials
PRT3645 Trials
PRT3789 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor Faqs
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact
About
A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.
About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
CDK9
MCL1
CDK4/6
SMARCA2
Discovery Engine
Publications
Clinical Trials
Overview
PRT2527 Trials
PRT1419 Trials
PRT3645 Trials
PRT3789 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor Faqs
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact
Prelude Therapeutics To Participate in Barclays Global Healthcare Conference
About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
CDK9
MCL1
CDK4/6
SMARCA2
Discovery Engine
Publications
Clinical Trials
Overview
PRT2527 Trials
PRT1419 Trials
PRT3645 Trials
PRT3789 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor Faqs
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact
